InvestorsHub Logo
Followers 8
Posts 2087
Boards Moderated 0
Alias Born 07/31/2006

Re: JG36 post# 95336

Thursday, 07/24/2014 1:42:36 PM

Thursday, July 24, 2014 1:42:36 PM

Post# of 146189
Right. And a $6B market cap. So yes, PUMA has clinical results, and the share price and market cap reflect that.

NNVC on the other hand is still a pre-clinical stage company, with a market cap what, about a 1/30th that of PUMA? So the NNVC market cap reflects your observation of no clinical results. And when NNVC enters into clinical trials and registers a few successes, will their market cap grow by 30:1 to match PUMA? I think so, yes.

best to all.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News